Get started
Author

Fatima Dagher

ORCID: 0000-0002-0219-8925
Observed ORCID: 0000-0002-0219-8925
OpenAlex ID: A5064019199
A review on the use of extracellular vesicles for the delivery of drugs and biological therapeutics
2024 · Sundus Jabeen Amina, Tasmia Azam, et al. · Expert Opinion on Drug Delivery · 21
Dietary phytochemical and metabolic disease prevention: Focus on plant proteins
2023 · Song-hong Yang, Gabriel Tao, et al. · Frontiers in Nutrition · 15
PDF
Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea
2022 · Gabriel Tao, Fatima Dagher, et al. · Food and Chemical Toxicology · 14
PDF
Neratinib causes non-recoverable gut injury and reduces intestinal cytochrome P450 3A enzyme in mice
2021 · Gabriel Tao, Fatima Dagher, et al. · Toxicology Research · 13
Role of oxidative stress in the efficacy and toxicity of herbal supplements
2020 · Gabriel Tao, Fatima Dagher, et al. · Current Opinion in Toxicology · 11
Abstract 3158: Pharmacokinetic and biodistribution evaluation of nebivolol and dasatinib in the 4T1 triple-negative breast cancer model: Implications for drug-drug interaction
2026 · Airong Li, Mikayla Skillman, et al. · Cancer Research · 1
Puberty and Sex Education Challenges in Adolescents With Autism Spectrum Disorder: Mixed-Methods Evidence From Lebanon
2026 · Issa Almoussawi, Hiba Barakat, et al. · Cureus · 1
PDF
Abstract 4347: Preclinical evaluation of pharmacokinetic interactions among nebivolol, dasatinib and devimistat in mice
2025 · Airong Li, Mikayla Skillman, et al. · Cancer Research · 1
Corrigendum to “Irinotecan decreases intestinal UDP-glucuronosyltransferase (UGT) 1A1 via TLR4/MyD88 pathway prior to the onset of diarrhea” [Food Chem. Toxicol. 166 (2022) 113246]
2022 · Gabriel Tao, Fatima Dagher, et al. · Food and Chemical Toxicology · 1
Abstract 3155: Pharmacokinetic/pharmacodynamic correlation and biodistribution of Re (CO)3-phenformin compared with phenformin in murine PDAC model following equimolar intravenous dosing
2026 · Amir Mohammad Gholizadeh, Fatima Dagher, et al. · Cancer Research
Abstract 4464: Repurposing nebivolol with CPI-613 for triple-negative breast cancer: Linking in-vitro synergy to in-vivo exposure.
2026 · Mikayla Skillman, Airong Li, et al. · Cancer Research
LC–MS/MS Assay for Simultaneous Quantification of Nebivolol, Dasatinib, and Devimistat and Its Application in Rats
2026 · Airong Li, Mikayla Skillman, et al. · Separation Science Plus
Abstract A123: Dual-Drug Micellar Approach to Overcome Stromal Barriers in Pancreatic Cancer
2025 · Fatima Dagher, Guodong Zhang, et al. · Cancer Research
Abstract 4359: Comprehensive pharmacokinetics of Re-phenformin as an anticancer agent for pancreatic cancer therapy in mice: a comparative study with phenformin
2025 · Amir Mohammad Gholizadeh, Fatima Dagher, et al. · Cancer Research
Abstract 2703: Effect of combination of calcipotriol with paclitaxel on pancreatic ductal adenocarcinoma orthotopic mouse model
2025 · Fatima Dagher, Mikayla Skillman, et al. · Cancer Research
Abstract 515: Repurposing nebivolol with dasatinib and CPI-613: A synergistic strategy to combat triple-negative breast cancer
2025 · Mikayla Skillman, Airong Li, et al. · Cancer Research
Abstract 7170: Pharmacokinetic profiling of Re-Phenformin in vivo: A novel approach in pancreatic cancer therapy
2024 · Amir Mohammad Gholizadeh, Lu Dai, et al. · Cancer Research
Abstract 5734: Polymeric delivery with dual drug payloads for hepatocellular carcinoma (HCC) therapy
2024 · Lu Dai, Guodong Zhang, et al. · Cancer Research
Works count: 18
Citation count: 78
H-index: 5
I10-index: 5
Year
Topic
Type